SBI Securities’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
SBI Securities's CLB Position: Q2 2026 in Review
SBI Securities sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 10 shares — an estimated $168 sold.
SBI Securities first reported a position in CLB in Q3 2025 and held it in 3 quarters. The position peaked at $321 in Q4 2025. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- SBI Securities reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
- SBI Securities sold 10 Core Laboratories shares in Q2 2026, an estimated $168.
- SBI Securities first reported a position in Core Laboratories in Q3 2025 and held it in 3 quarters.
- SBI Securities's Core Laboratories position peaked at $321 in Q4 2025.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.